Stanley Laman Group, Ltd. Insulet Corp Transaction History

Stanley Laman Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$161.02 - $206.98 $1.04 Million - $1.34 Million	-6,477 Reduced 8.85%	66,681 $13.5 Million
Q1 2024 Apr 17, 2024	BUY	$163.6 - $209.11 $12 Million - $15.3 Million	73,158 New	73,158 $12.5 Million
Q1 2022 Apr 21, 2022	SELL	$194.8 - $275.7 $171,034 - $242,064	-878 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$255.32 - $318.29 $224,170 - $279,458	878 New	878 $234,000

713

62.9M

640K

858K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.